Core Laboratories (CLB) Set to Announce Earnings on Wednesday

Core Laboratories (NYSE:CLB) will be announcing its earnings results after the market closes on Wednesday, July 24th. Analysts expect Core Laboratories to post earnings of $0.21 per share for the quarter. Core Laboratories has set its Q2 guidance at $0.19-0.23 EPS and its Q2 2024 guidance at 0.190-0.230 EPS.Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Core Laboratories (NYSE:CLB) last issued its earnings results on Wednesday, April 24th. The oil and gas company reported $0.13 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.02. Core Laboratories had a net margin of 8.18% and a return on equity of 15.71%. The company had revenue of $129.64 million for the quarter, compared to the consensus estimate of $124.47 million. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Stock Performance

Core Laboratories stock opened at $22.63 on Tuesday. The firm has a 50 day simple moving average of $19.47 and a 200-day simple moving average of $17.27. The stock has a market cap of $1.06 billion, a price-to-earnings ratio of 25.72, a price-to-earnings-growth ratio of 1.45 and a beta of 2.41. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.68 and a quick ratio of 1.85. Core Laboratories has a 1-year low of $13.82 and a 1-year high of $27.94.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 28th. Investors of record on Monday, May 6th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.18%. The ex-dividend date was Friday, May 3rd. Core Laboratories’s dividend payout ratio is presently 4.55%.

Analysts Set New Price Targets

Several equities analysts have recently commented on CLB shares. Piper Sandler decreased their price target on Core Laboratories from $18.00 to $17.00 and set a “neutral” rating on the stock in a research note on Monday, July 15th. Bank of America decreased their target price on shares of Core Laboratories from $16.00 to $15.00 and set an “underperform” rating on the stock in a research report on Monday, July 15th. StockNews.com lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Wednesday, July 10th. Finally, Stifel Nicolaus boosted their price target on shares of Core Laboratories from $17.00 to $18.00 and gave the company a “hold” rating in a research note on Friday, April 26th. Three analysts have rated the stock with a sell rating and two have assigned a hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $17.50.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.